Evidence map›Paper›PMID 37731017›Full record

ArticleScientific reports2023

Experimental and DFT study of photocatalytic activity of reduced graphene oxide/copper sulfide composite for removal of organic dyes from water.

Mohamed S Sadek, Ghada E Khedr, Michel F Abdel Messih, Mohamed Abdel Hay Ismail

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Design of Al-decorated CRSC advances · 2026
    Article
  3. Hierarchical CoACS omega · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed S SadekChemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt. msaed@rocketmail.com.
Ghada E KhedrDepartment of Analysis and Evaluation, Egyptian Petroleum Research Institute (EPRI), Cairo, 11727, Egypt.
Michel F Abdel MessihChemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt.
Mohamed Abdel Hay IsmailChemistry Department, Faculty of Science, Ain-Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, successful nanocomposites composed of different ratios of reduced graphene oxide and copper sulphide (xCuS-rGO) were fabricated to aid in treating water contaminated with organic dyes. XRD, TEM, SEM, XPS, IR, EDX and BET were applied for the characterization of (CuS-rGO). The photocatalytic strength of the prepared nanocomposites was evaluated using artificial sunlight irradiation. The nanocomposites were tested for their ability to degrade both anionic and cationic organic dyes, including amaranth and rhodamine B (RhB). The excellent photocatalytic strength of our composites, relative to pristine CuS and rGO, was interpreted as rGO sheets being very porous. In addition, the charge moved efficiently from rGO to CuS. The combined properties enhanced the efficiency of photodegradation of CuS-rGO composite across the dyes under the illumination of simulated sunlight. The electron transportation from rGO sheets to the CuS conduction band enhances the charge separation and transportation. The role of superoxide radicals in photocatalytic degradation was unveiled and the interactions between the studied dyes and our catalysts were investigated by density functional theory study and scavenging investigation. This work gives new ideas about the preparation and properties of (CuS-rGO) composites and their broad application in solving environmental problems.

Identifiers

PMID37731017
PMCPMC10511407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.